Literature DB >> 10434306

Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain.

J C Dorsman1, M A Smoor, M L Maat-Schieman, M Bout, S Siesling, S G van Duinen, J J Verschuuren, J T den Dunnen, R A Roos, G J van Ommen.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder with a midlife onset. The disease is caused by expansion of a CAG (glutamine) repeat within the coding region of the HD gene. The molecular mechanism by which the mutated protein causes this disease is still unclear. To study the protein we have generated a set of rabbit polyclonal antibodies raised against different segments of the N-terminal, central and C-terminal parts of the protein. The polyclonal antibodies were affinity purified and characterized in ELISA and Western blotting experiments. All antibodies can react with mouse and human proteins. The specificity of these antibodies is underscored by their recognition of huntingtin with different repeat sizes in extracts prepared from patient-derived lymphoblasts. The antibodies were used in immunofluorescence experiments to study the subcellular localization of huntingtin in mouse neuroblastoma NIE-115 cells. The results indicate that most huntingtin is present in the cytoplasm, whereas a minor fraction is present in the nucleus. On differentiation of the NIE-115 cells in vitro, the subcellular distribution of huntingtin does not change significantly. These results suggest that full-length huntingtin with a normal repeat length can be detected in the nucleus of cycling and non-cycling cultured mammalian cells of neuronal origin. However, in HD autopsy brain the huntingtin-containing neuronal intranuclear inclusions can be detected only with antibodies raised against the N-terminus of huntingtin. Thus several forms of huntingtin display the propensity for nuclear localization, possibly with different functional consequences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434306      PMCID: PMC1692596          DOI: 10.1098/rstb.1999.0459

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  22 in total

1.  Maturation of neuroblastoma cells in the presence of dimethylsulfoxide.

Authors:  Y Kimhi; C Palfrey; I Spector; Y Barak; U Z Littauer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

2.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.

Authors:  Y P Goldberg; D W Nicholson; D M Rasper; M A Kalchman; H B Koide; R K Graham; M Bromm; P Kazemi-Esfarjani; N A Thornberry; J P Vaillancourt; M R Hayden
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Huntington's disease: testing the test.

Authors:  A P Read
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

4.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

5.  Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.

Authors:  M L Maat-Schieman; J C Dorsman; M A Smoor; S Siesling; S G Van Duinen; J J Verschuuren; J T den Dunnen; G J Van Ommen; R A Roos
Journal:  J Neuropathol Exp Neurol       Date:  1999-02       Impact factor: 3.685

6.  A huntingtin-associated protein enriched in brain with implications for pathology.

Authors:  X J Li; S H Li; A H Sharp; F C Nucifora; G Schilling; A Lanahan; P Worley; S H Snyder; C A Ross
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein.

Authors:  Y S Jou; R M Myers
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

8.  Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.

Authors:  K E De Rooij; P A De Koning Gans; M I Skraastad; R D Belfroid; M Vegter-Van Der Vlis; R A Roos; E Bakker; G J Van Ommen; J T Den Dunnen; M Losekoot
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

9.  Characterization and localization of the Huntington disease gene product.

Authors:  A T Hoogeveen; R Willemsen; N Meyer; K E de Rooij; R A Roos; G J van Ommen; H Galjaard
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

10.  Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells.

Authors:  O Kranenburg; V Scharnhorst; A J Van der Eb; A Zantema
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more
  6 in total

Review 1.  Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases.

Authors:  Yraima Cordeiro; Bruno Macedo; Jerson L Silva; Mariana P B Gomes
Journal:  Biophys Rev       Date:  2014-01-09

Review 2.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

3.  Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.

Authors:  Caroline L Benn; Tingting Sun; Ghazaleh Sadri-Vakili; Karen N McFarland; Derek P DiRocco; George J Yohrling; Timothy W Clark; Bérengère Bouzou; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 4.  Wild-type huntingtin plays a role in brain development and neuronal survival.

Authors:  Anton Reiner; Ioannis Dragatsis; Scott Zeitlin; Daniel Goldowitz
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

5.  Huntingtin localisation studies - a technical review.

Authors:  Alis Hughes; Lesley Jones
Journal:  PLoS Curr       Date:  2011-02-16

6.  Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.

Authors:  Kathryn R Bowles; Simon P Brooks; Stephen B Dunnett; Lesley Jones
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.